Although insulin resistance or diabetes enhances PD-related pathogeneses in in vivo and in vitro neuronal models (Bousquet et al., 2012; Solmaz et al., 2017; Hong et al., 2020), biological evidence in human studies is lacking and the functional assessment of insulin signaling pathway in PD patients’ neurons is challenging. This evidence concerns the gene INS and Parkinson disease.